Honeybear Biosciences
  • About Honeybear
  • Pipeline
  • Products
  • Latest news
  • Contact us
  • English
    繁體中文
  • About Honeybear
  • Pipeline
  • Products
  • Latest news
  • Contact us
Innovation Integrity Responsibility

Latest news

Home / Latest news
HoneyBear Biosciences Leads Taiwan's ARC Initiative

HoneyBear Biosciences Leads Taiwan's ARC Initiative

Read more
HoneyBear Biosciences and A*STAR Team Successfully Complete Two Licensing Agreements in Singapore

HoneyBear Biosciences and A*STAR Team Successfully Complete Two Licensing Agreements in Singapore

Read more
2025 Asia Pacific Biopharma Excellence Awards (ABEA)

2025 Asia Pacific Biopharma Excellence Awards (ABEA)

Read more
Dr. Chuang, Simon, Shih-Hsien, CEO of HoneyBear Biosciences, invited to give a speech at ADC Congress Asia

Dr. Chuang, Simon, Shih-Hsien, CEO of HoneyBear Biosciences, invited to give a speech at ADC Congress Asia

Read more
Special Interview on Startup 101—"Next-Generation Cancer Drug Platform, Becoming a Lifeline for Patients: Interview with HoneyBear Biosciences"

Special Interview on Startup 101—"Next-Generation Cancer Drug Platform, Becoming a Lifeline for Patients: Interview with HoneyBear Biosciences"

Read more
2024 World ADC

2024 World ADC

Read more
"The International Marketing Award", 2024 NBRP DEMO DAY

"The International Marketing Award", 2024 NBRP DEMO DAY

Read more
“Process For Preparing Glycoprotein-Drug Conjugates”awarded with Silver award of the 8th National invention and creation award granted by Ministry of Economic Affairs.

“Process For Preparing Glycoprotein-Drug Conjugates”awarded with Silver award of the 8th National invention and creation award granted by Ministry of Economic Affairs.

Read more
Simon Shih-Hsien Chuang, CEO of Honeybear Biosciences invited to give a speech in 2023 BioAsia

Simon Shih-Hsien Chuang, CEO of Honeybear Biosciences invited to give a speech in 2023 BioAsia

Read more
“First ADC drug with dual anti-cancer effects worldwide” press conference on March 13th, 2023

“First ADC drug with dual anti-cancer effects worldwide” press conference on March 13th, 2023

Read more
Booth exhibition in 2023 BioAsia, July 26 - 30, 2023, Taiwan

Booth exhibition in 2023 BioAsia, July 26 - 30, 2023, Taiwan

Read more
Honeybear Biosciences
  • Tel.
    +886-2-26530168
  • Address.
    Room C518, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei City 115021, Taiwan
  • E-Mail.
    service@honeybearbio.com
  • Designed by GTUT
  • Site Map
  • Manage Cookies
  • The best browsing environment on this site, please use Google Chrome, Firefox or Edge or above